Literature DB >> 10950921

Characterization of the human TESTIN gene localized in the FRA7G region at 7q31.2.

C Tatarelli1, A Linnenbach, K Mimori, C M Croce.   

Abstract

Cancer-associated chromosomal aberrations often involve regions containing fragile sites. FRA7G is a common aphidicolin-inducible fragile site at 7q31.2, showing loss of heterozygosity in human malignancies. To investigate the structure of FRA7G, we constructed a bacterial artificial chromosome contig spanning the region between marker D7S486 and Met H. Analysis of the FRA7G sequence allowed us to identify a gene encoding a 421-amino-acid protein with three LIM domains and 89% identity to murine Testin. We determined the genomic structure of the human TESTIN locus and characterized three alternative transcripts. Although TESTIN mRNA is expressed in all normal human tissues examined, we observed lack of expression in 22% of cancer cell lines and 44% of the cell lines derived from hematological malignancies. We further determined that in most of these cases the inactivation of TESTIN expression is due to methylation of a CpG island. Analysis of the TESTIN coding region in 26 tumor cell lines revealed three missense mutations. Our findings suggest that TESTIN may represent a candidate tumor suppressor gene at 7q31.2. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10950921     DOI: 10.1006/geno.2000.6272

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  31 in total

1.  Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity.

Authors:  Marcel W Coolen; Clare Stirzaker; Jenny Z Song; Aaron L Statham; Zena Kassir; Carlos S Moreno; Andrew N Young; Vijay Varma; Terence P Speed; Mark Cowley; Paul Lacaze; Warren Kaplan; Mark D Robinson; Susan J Clark
Journal:  Nat Cell Biol       Date:  2010-02-21       Impact factor: 28.824

2.  Comprehensive analysis of transcriptional promoter structure and function in 1% of the human genome.

Authors:  Sara J Cooper; Nathan D Trinklein; Elizabeth D Anton; Loan Nguyen; Richard M Myers
Journal:  Genome Res       Date:  2005-12-12       Impact factor: 9.043

Review 3.  Common fragile genes and digestive tract cancers.

Authors:  Tamotsu Kuroki; Yoshitsugu Tajima; Jyunichiro Furui; Takashi Kanematsu
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

4.  Identification of a new target region on the long arm of chromosome 7 in gastric carcinoma by loss of heterozygosity.

Authors:  De-Sheng Weng; Jin-Tian Li; Shi-Juan Mai; Zhi-Zhong Pan; Bing-Jian Feng; Qi-Sheng Feng; Li-Xi Huang; Qi-Jing Wang; Yong-Qiang Li; Xing-Juan Yu; Shi-Ping Chen; Jia He; Jian-Chuan Xia
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

5.  TES was epigenetically silenced and suppressed the epithelial-mesenchymal transition in breast cancer.

Authors:  Yang Yongbin; Li Jinghua; Zhao Zhanxue; Zang Aimin; Jia Youchao; Shang Yanhong; Jiao Manjing
Journal:  Tumour Biol       Date:  2014-08-15

6.  AlphaII-spectrin interacts with Tes and EVL, two actin-binding proteins located at cell contacts.

Authors:  Björn Rotter; Odile Bournier; Gael Nicolas; Didier Dhermy; Marie-Christine Lecomte
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

7.  The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation.

Authors:  Dallas R Donohoe; Leonard B Collins; Aminah Wali; Rebecca Bigler; Wei Sun; Scott J Bultman
Journal:  Mol Cell       Date:  2012-10-11       Impact factor: 17.970

8.  Extensive analysis of D7S486 in primary gastric cancer supports TESTIN as a candidate tumor suppressor gene.

Authors:  Haiqing Ma; Desheng Weng; Yibing Chen; Wei Huang; Ke Pan; Hui Wang; Jiancong Sun; Qijing Wang; Zhiwei Zhou; Huiyun Wang; Jianchuan Xia
Journal:  Mol Cancer       Date:  2010-07-13       Impact factor: 27.401

9.  Zinc finger protein 185 is a liver metastasis-associated factor in colon cancer patients.

Authors:  Daisuke Furukawa; Tsuyoshi Chijiwa; Masahiro Matsuyama; Masaya Mukai; Ei-Ichi Matsuo; Osamu Nishimura; Kenji Kawai; Hiroshi Suemizu; Nobuyoshi Hiraoka; Toshio Nakagohri; Seiei Yasuda; Masato Nakamura
Journal:  Mol Clin Oncol       Date:  2014-05-29

10.  Fragile site orthologs FHIT/FRA3B and Fhit/Fra14A2: evolutionarily conserved but highly recombinogenic.

Authors:  Ayumi Matsuyama; Takeshi Shiraishi; Francesco Trapasso; Tamotsu Kuroki; Hansjuerg Alder; Masaki Mori; Kay Huebner; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.